Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers

References

• Nakken O, Lindstrom JC, Tysnes OB, Holmoy T. Mortality trends of amyotrophic lateral sclerosis in Norway 1951–2014: an age-period-cohort study. J Neurol. 2016;263:2378–85.
   PubMed Web of Science ®Google Scholar
• Tysnes OB, Vollset SE, Aarli JA. Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand. 1991;83:280–5.
   PubMed Web of Science ®Google Scholar
• Gundersen MD, Yaseen R, Midgard R. Incidence and clinical features of amyotrophic lateral sclerosis in Møre and Romsdal County, Norway. Neuroepidemiology. 2011;37:58–63.
   PubMed Web of Science ®Google Scholar
• Alcaz S, Jarebinski M, Pekmezovic T, Stevic-Marinkovic Z, Pavlovic S, Apostolski S. Epidemiological and clinical characteristics of ALS in Belgrade, Yugoslavia. Acta Neurol Scand. 1996;94:264–8.
   PubMed Web of Science ®Google Scholar
• Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165–70.
   PubMed Web of Science ®Google Scholar
• Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta. 2006;1762:1150–7.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41:118–30.
   PubMed Web of Science ®Google Scholar
• Public Health Portal for citizens in Norway. Exemption card for public health services. 2017. Available at: https://helsenorge.no/foreigners-in-norway/exemption-card-for-public-health-services?redirect=false. Accessed June 10, 2017.
   Google Scholar
• Simpson S Jr, Taylor BV. The scandinavian paradox revisited: editorial comment on Berg-Hansen et al. ‘High prevalence and no latitude gradient of multiple sclerosis in Norway’. Mult Scler. 2014;20:1675–7.
   PubMed Web of Science ®Google Scholar
• Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011;36:29–38.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
   PubMed Web of Science ®Google Scholar
• Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.
   PubMedGoogle Scholar
• Nygren I, Antonova K, Mattsson P, Askmark H. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics. Acta Neurol Scand. 2005;111:180–4.
   PubMed Web of Science ®Google Scholar
• Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology. 2007;29:44–8.
   PubMed Web of Science ®Google Scholar
• Guidetti D, Bondavalli M, Sabadini R, Marcello N, Vinceti M, Cavalletti S, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology. 1996;15:301–12.
   PubMed Web of Science ®Google Scholar
• Huber S, Henn V. Unchanged incidence and prevalence of amyotrophic lateral sclerosis in the canton of Zurich. Schweiz Arch Neurol Psychiatr. 1995;146:52–4.
   PubMedGoogle Scholar
• Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003;60:683–9.
   PubMed Web of Science ®Google Scholar
• Cetin H, Rath J, Fuzi J, Reichardt B, Fulop G, Koppi S, et al. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course. Neuroepidemiology. 2015;44:6–15.
   PubMed Web of Science ®Google Scholar
• Pugliatti M, Parish LD, Cossu P, Leoni S, Ticca A, Saddi MV, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009. J Neurol. 2013;260:572–9.
   PubMed Web of Science ®Google Scholar
• Weil C, Zach N, Rishoni S, Shalev V, Chodick G. Epidemiology of amyotrophic lateral sclerosis: a population-based study in Israel. Neuroepidemiology. 2016;47:76–81.
   PubMed Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557–63.
   PubMed Web of Science ®Google Scholar
• Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330:585–91.
   PubMed Web of Science ®Google Scholar
• Norwegian prescription database. Startpage Norwegian prescription database. 2017. Available at: http://www.reseptregisteret.no/
   Google Scholar
• Tollefsen E, Midgren B, Bakke P, Fondenes O. Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation. Eur J Neurol. 2010;17:1352–7.
   PubMed Web of Science ®Google Scholar
• Indrekvam S, Fondenes O, Gjerdevik M, Tysnes O-B, Rekand T, Bakke P. Longterm mechanical ventilation in ALS – Outcome and perspective. A 12-year national register study of non-invasive and invasive ventilation in Norway. Eur Respir J. 2015;46:PA1571.
   Web of Science ®Google Scholar
• Dreyer P, Lorenzen CK, Schou L, Felding M. Survival in ALS with home mechanical ventilation non-invasively and invasively: a 15-year cohort study in west Denmark. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:62–7.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
   PubMed Web of Science ®Google Scholar
• Holmoy T, Braaten O, Hovden IA, Tallaksen CM. [A young woman with a weakening leg]. Tidsskr Nor Laegeforen. 2011;131:583–6.
   PubMedGoogle Scholar
• Ostern R, Fagerheim T, Orstavik K, Holmoy T, Heiberg A, Lund-Petersen I, et al. Hereditary motor neuron disease in a large Norwegian family with a “H46R” substitution in the superoxide dismutase 1 gene. Neuromuscul Disord. 2012;22:511–21.
   PubMed Web of Science ®Google Scholar
• Zou ZY, Liu MS, Li XG, Cui LY. H46R SOD1 mutation is consistently associated with a relatively benign form of amyotrophic lateral sclerosis with slow progression. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:610–13.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Pupillo E, Messina P, Logroscino G, Beghi E. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol. 2014;75:287–97.
   PubMed Web of Science ®Google Scholar
• Bookwala J, Coppola KM, Fagerlin A, Ditto PH, Danks JH, Smucker WD. Gender differences in older adults' preferences for life-sustaining medical treatments and end-of-life values. Death Studies. 2001;25:127–49.
   PubMed Web of Science ®Google Scholar
• van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. The Lancet. 2017;390:2084–98.
   PubMed Web of Science ®Google Scholar
• Tollefsen E, Gulsvik A, Bakke P, Fondenes O. Prevalence of home ventilation therapy in Norway. Tidsskr Nor laegeforen. 2009;129:2094–7.
   PubMedGoogle Scholar
• Aarli JA, Tysnes OB. Five-year experience with a clinic for amyotrophic lateral sclerosis. Tidsskr Nor Laegeforen. 1997;117:1892–5.
   PubMedGoogle Scholar
• Stickler DE, Royer JA, Hardin JW. Validity of hospital discharge data for identifying cases of amyotrophic lateral sclerosis. Muscle Nerve. 2011;44:814–16.
   PubMed Web of Science ®Google Scholar
• Kab S, Moisan F, Preux PM, Marin B, Elbaz A. Nationwide incidence of motor neuron disease using the French health insurance information system database. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:426–33.
   PubMed Web of Science ®Google Scholar